Morgan-Ortiz, Fred; Burgos-Tamayo, Juan Carlos; Quevedo-Castro E, Morgan-Ruiz FV, Báez-Barraza J, Peraza-Garay FJ

Language: Spanish
References: 21
Page: 650-657
PDF size: 282.73 Kb.

ABSTRACT

Objective: To evaluate the menstrual pattern and ovarian reserve in patients undergoing salpingectomy and bilateral tubal occlusion as definitive sterilization methods.
Material and Methods: A prospective, longitudinal, comparative, experimental, randomized, single blind study was carried out in patients with a desire for definitive sterilization as a contraceptive method. Patients were randomly assigned to perform bilateral tubal occlusion or salpingectomy. Six months after the procedure in each patient, the menstrual pattern and the serum determination of follicle stimulating hormone (FSH) and the antral follicle count were evaluated by transvaginal ultrasound as markers of ovarian reserve. The statistical analysis was carried out using the student's t-test for independent samples (comparison between groups) and dependent samples (intra-group comparison) for comparison of means and the χ² test for comparison of proportions.
Results: Sixty patients were studied, 31 with bilateral tubal occlusion and 29 with salpingectomy. Significant increases were observed in the days of menstrual bleeding with respect to the baseline after bilateral tubal occlusion (p = .002) and salpingectomy (p = .008). No differences were observed between bilateral tubal occlusion and salpingectomy with respect to the surgical time to carry out the sterilization technique (p = .83), menstrual cycle duration (p = .35), duration of the days of menstrual bleeding (p = .40). No differences were observed in the serum levels of FSH (p = .75) nor in the antral follicle count (p = .44) between the groups.
Conclusions: The menstrual pattern and the ovarian reserve are very similar in patients who undergo bilateral tubal occlusion and salpingectomy, although the two techniques increase the duration of menstrual bleeding after the procedure.

REFERENCES

1. Sadatmahalleh SJ, et al. Menstrual pattern following tubal ligation: a historical cohort study. Int J Fertil Steril. 2016;9(4):477-82. doi: 10.22074/ijfs.2015.4605

2. Peterson HB, et al. The risk of menstrual abnormalities after tubal sterilization. N Engl J Med. 2000;343(23):1681-7. doi: 10.1056/NEJM200012073432303

3. Shobeiri MJ, et al. The risk of menstrual abnormalities after tubal sterilization: a case control study. BMC Women's Health 2005;5 (1):5. https://doi.org/10.1186/1472-6874-5-5

4. Gentile GP, et al. Is there any evidence for a post-tubal sterilization syndrome? Fertil Steril. 1998;69(2):179-86. https://doi.org/10.1016/S0015-0282(97)00229-X

5. Harlow BL, et al. Does tubal sterilization influence the subsequent risk of menorrhagia or dysmenorrhea? Fertil Steril. 2002;77(4):754-60. https://doi.org/10.1016/S0015- 0282(01)03253-8

6. Peterson HB, et al. The risk of pregnancy after tubal sterilization: Findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol 1996;174(4):1161-8. https://doi.org/10.1016/S0002-9378(96)70658-0

7. Danis RB, et al. Postpartum Permanent Sterilization: Could Bilateral Salpingectomy Replace Bilateral Tubal Ligation? J Minim Invasive Gynecol. 2016;23(6):928-32. https://doi. org/10.1016/j.jmig.2016.05.006

8. Browning K, et al. Salpingectomy for Sterilization: A New Standard of Care? Topics Obstet Gynecol 2015;35 (14):1-5. doi: 10.1097/01.PGO.0000469166.43874.52

9. Broekmans FJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12(6):685-718. https://doi.org/10.1093/humupd/ dml034

10. Brodin T, et al. Comparing four ovarian reserve markers – associations with ovarian response and live births after assisted reproduction. Acta Obstet Gynecol Scand. 2015;94(10):1056-63. https://doi.org/10.1111/aogs.12710

11. Jamil Z, et al. Assessment of ovarian reserve: Anti‑Mullerian hormone versus follicle stimulating hormone. J Res Med Sci. 2016;21:100. doi: 10.4103/1735-1995.193172

12. Riggs RM, et al. Assessment of ovarian reserve with anti- Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age. Am J Obstet Gynecol. 2008;199(2):202. e1-8. https://doi.org/10.1016/j.ajog.2008.05.004

13. Capecce E, et al. La hormona antimülleriana como marcador de función ovárica. Rev Argent Endocrinol Metab 2016;53:106-13. doi: 10.1016/j.raem.2016.06.003

14. Committee on Gynecologic Practice. Ovarian reserve testing. Obstet Gynecol. 2015 Jan;125(1):268-73. doi: 10.1097/01.AOG.0000459864.68372.ec.

15. Qin F, et al. The effect of salpingectomy on ovarian reserve and ovarian function. Obstet Gynecol Surv. 2016;71(6):369- 76. doi: 10.1097/OGX.0000000000000323

16. Kotlyar A, et al. The effect of salpingectomy on ovarian Function. J Minim Invasive Gynecol. 2017;24(4):563-578. https://doi.org/10.1016/j.jmig.2017.02.014

17. Kelekci S, et al. Ovarian reserve and ovarian stromal blood supply after tubal ligation by the Pomeroy technique: Comparison with controls. Gynecol Endocrinol. 2005;20(5):279- 83. https://doi.org/10.1080/09513590500097192

18. Venturella R, et al E. 3 to 5 Years Later: Long-term Effects of Prophylactic Bilateral Salpingectomy on Ovarian Function. J Minim Invasive Gynecol. 2017 Jan 1;24(1):145-50. https:// doi.org/10.1016/j.jmig.2016.08.833

19. Alipour F, et al. Comparison of Specificity and Sensitivity of AMH and FSH in Diagnosis of Premature Ovarian Failure. Dis Markers. 2015. http://dx.doi.org/10.1155/2015/585604

20. Swanson CL, et al. Options in Prophylactic Surgery to Prevent Ovarian Cancer in High-Risk Women: How New Hypotheses of Fallopian Tube Origin Influence Recommendations. Curr Treat Options Oncol. 2016;17(5):20. https:// doi.org/10.1007/s11864-016-0396-2

21. Anderson RA, et al. Measuring anti-Müllerian hormone for the assessment of ovarian reserve: when and for whom is it indicated? Maturitas 2012;71(1):28-33. https://doi. org/10.1016/j.maturitas.2011.11.008